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Earlier reports have shown that the d120 mutant of herpes simplex virus 1 lacking both copies of the gene encoding the
infected cells protein No. 4 (ICP4) induces apoptosis in a variety of cell lines. The programmed cell death induced by this
mutant is blocked by overexpression of Bcl-2 or by transduction of infected cells with the gene encoding the viral US3 protein
kinase. HEp-2 cells infected with the d120 mutant express predominantly  proteins. Studies on these proteins revealed the
accumulation of a Mr 37,500 protein that reacted with antibody directed against the carboxyl-terminal domain of ICP22. We
report that theMr 37,500 protein is a product of the proteolytic cleavage of ICP22 by a caspase activated by the d120 mutant.
Thus the accumulation of the Mr 37,500 protein was blocked in cells transduced with the US3 protein kinase, in cells
overexpressing Bcl-2, or in infected cells treated with the general caspase inhibitor zVAD-fmk. Exposure of ICP22 made in
wild-type virus-infected cells to caspase 3 yielded two polypeptides, of which one could not be differentiated from the Mrconclud
viral protein for destruction. © 2003 Elsevier Science (USA)
INTRODUCTION
Earlier reports have shown that herpes simplex virus 1
(HSV-1) blocks programmed cell death induced by a
variety of agents including sorbitol, Fas ligand, tumor
necrosis factor , etc. (Asano et al., 1999, 2000; Aubert
and Blaho, 1999; Aubert et al., 1999; Galvan et al., 1999,
2000; Galvan and Roizman, 1998; Hata et al., 1999;
Jerome et al., 1999; Koyama and Miwa, 1997; Leopardi
and Roizman, 1996; Leopardi et al., 1997a; Munger and
Roizman, 2001; Sieg et al., 1996; Zhou et al., 2000; Zhou
and Roizman, 2000, 2001). Whereas wild-type HSV-1
does not induce apoptosis, several mutants have been
shown to induce apoptosis in a variety of cell lines
(Asano et al., 1999, 2000; Aubert and Blaho, 1999; Aubert
et al., 1999; Galvan et al., 1999, 2000; Galvan and Roiz-
man, 1998; Leopardi and Roziman, 1996; Leopardi et al.,
1997a; Zhou et al., 2000). This article concerns a mutant
(d120) that lacks both copies of 4, the gene-encoding
infected cell protein No. 4 (ICP4), a negative and positive
regulator of gene expression. In cells infected with this
mutant the  proteins accumulate in large amounts. A
major characteristic of the infected cells is extensive
cytopathology characteristic of apoptosis (Leopardi and
Roizman, 1996). The d120 mutant induces apoptosis in
virtually all cell lines tested to date, although the mech-
anism by which it induces programmed cell death ap-
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364pears to be cell line dependent (Galvan et al., 1999;
Galvan and Roizman, 1998). In recent studies it has been
shown that stable transduction and overexpression of
Bcl-2, or transient expression of the US3 protein kinase
encoded by the HSV-1, blocks the proapoptotic activity of
the d120 mutant in HEp-2 cells (Munger et al., 2001).
In the course of studying the proteins made in d120
mutant-infected cells, we noted that the antibody to
ICP22 reacted with a novel protein with an apparent M r
of 37,500. This protein does not accumulate in cells
infected with wild-type virus. In this article we show that
the M r 37,500 protein is a caspase cleavage product of
ICP22. Thus the accumulation of the M r 37,500 protein
was blocked in cells transduced with the US3 protein
kinase, in cells overexpressing Bcl-2, or in cells treated
with the general caspase inhibitor zVAD-fmk. Exposure
of ICP22 made in wild type-virus infected cells to
caspase 3 yield two polypeptides, one of which could not
be differentiated from the M r 37,500 protein with respect
to electrophoretic electrophoretic mobility.
Relevant to this article are the following: ICP22 is a
product of the 22 gene. The domain of this gene en-
codes two polypeptides. ICP22 is translated from an
mRNA that is spliced immediately 5 of the open reading
frame. The US1.5 protein is translated from an unspliced
message transcribed from sequences contained within
the 22 open reading frame, and the US1.5 ORF is col-
linear with the middle and carboxyl-terminal domains of
the ICP22 ORF (Carter and Roizman, 1996). Neither 2237,500 protein with respect to electrophoretic mobility. We
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nor US1.5 are essential for viral replication in cultured
cells but the mutants lacking the 22 gene are highly
attenuated in experimental animals (Poffenberger et al.,
1994). The mutants grow as well as wild-type virus in
HEp-2 or Vero cells but show a reduced capacity to
replicate in primary human cells or rabbit or rodent cells.
In these cells the expression of a subset of late (2)
genes exemplified by UL38 and US11 is grossly reduced
(Ogle and Roizman, 1999; Purves et al., 1993). A mutant
virus expressing the US1.5 protein but not ICP22 accu-
mulates amounts of UL38 and US11 proteins similar to
that observed in wild-type virus-infected cells but is avir-
ulent in mice (Ogle and Roizman, 1999). More recent
studies have shown that the expression of this subset of
late genes is dependent on the presence of both the
22/US1.5 gene and the protein kinase induced by the
UL13 protein kinase and is mediated by the activation of
the cdc2 cyclin-dependent kinase (Advani et al., 2000;
Purves et al., 1993).
RESULTS
Appearance of an additional ICP22 immunoreactive
band in lysates of cells infected with the d120 mutant
To examine the specific forms of ICP22 present during
various wild-type or mutant HSV infections, HEp-2 cells
were mock-infected, infected with HSV-1(F), or infected
with either the d120 mutant or R7041 (US3). The cells
were harvested at 18 h after infection, solubilized, elec-
trophoretically separated in denaturing polyacrylamide
gels, transferred to a nitrocellulose sheet, and reacted
with antibody raised to the carboxyl-terminal domain of
ICP22. As shown in Fig. 1, abundant expression of ICP22
and to a lesser extent of the US1.5 proteins was detected
in HSV-1(F), d120, and R7041-infected cells, but not in
mock-infected cells. ICP0 was also detected in cells
infected with HSV-1(F)-, d120-, and R7041 (data not
shown).
An ICP22 immunoreactive band with an apparent M r
an apparent M r of approximately 37,500 was abundant in
d120-infected cells and to a much lesser extent in R7041
mutant-infected cells but was not detected in HSV-1(F)-
infected cells (Fig. 1, compare lane 2 with lanes 3 and 4).
The electrophoretic mobility of the M r 37,500 ICP22 im-
munoreactive protein band is greater than that of the
US1.5 band that is detectable in lysates of cells infected
with HSV-1(F), d120, or R7041 viruses (Fig. 1, lanes 2, 3,
and 4).
To examine the temporal pattern of appearance of the
M r 37,500 protein, HEp-2 cells were mock infected or
infected with the d120 mutant, harvested at various
times after infection, solubilized, electrophoretically sep-
arated in denaturing polyacrylamide gels, transferred to
a nitrocellulose sheet, and reacted with antibody raised
to the carboxyl-terminal domain of ICP22. As shown in
Fig. 2, the M r 37,500 protein (arrow) was first detected in
significant amounts at 15 h (lane 2) and increased in
amount by 20 h after infection.
Prevention of d120 induced apoptosis precludes the
accumulation of the Mr 37,500 protein
Two series of experiments were done to test the hy-
pothesis that the M r 37,500 protein arose as a conse-
quence of apoptosis induced by the d120 mutant. In the
first series we made use of a HEp-2 cell line (VAX-3) that
FIG. 1. Photograph of electrophoretically separated cell lysates re-
acted with polyclonal rabbit antibody to the carboxy-terminus of ICP22.
Replicate 25-cm2 flask cultures of HEp-2 cells were mock-infected or
infected for 18 h at 37°C with 10 PFU of HSV-1(F), d120, R7041, or gD/
per cell; harvested; solubilized; electrophoretically separated on dena-
turing gels; electrically transferred to a nitrocellulose sheet; and re-
acted with rabbit antibody to the carboxy-terminus of ICP22.
FIG. 2. Photograph of electrophoretically separated cell lysates re-
acted with polyclonal rabbit antibody to the carboxy-terminus of ICP22.
Replicate 25-cm2 flask cultures of HEp-2 cells were mock-infected for
18 h or infected with 10 PFU of the d120 mutant per cell, harvested at
the indicated time points, solubilized, electrophoretically separated on
denaturing gels, electrically transferred to a nitrocellulose sheet, and
reacted with rabbit antibody to the carboxy-terminus of ICP22.
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overexpresses the bcl-2 protein and blocks d120-in-
duced apoptosis (Galvan et al., 2000). In addition we
tested the effects of the general caspase inhibitor z-VAD-
fmk, which also blocks d120-induced apoptosis in HEp-2
cells (Galvan et al., 2000). Replicate cultures of the bcl-2
overexpressing cells (VAX-3) or the parent, HEp-2 cells,
were either mock infected or infected with HSV-1(F), or
the d120 mutant in the presence or absence of 25 or 50
M z-VAD-fmk. The cells were harvested at 18 h after
mock infection or infection, solubilized, electrophoreti-
cally separated in denaturing polyacrylamide gels, trans-
ferred to a nitrocellulose sheet, and reacted with anti-
body raised to the carboxyl terminus of ICP22. The re-
sults shown in Fig. 3 were as follows: The M r 37,500
protein (arrow) accumulated in d120-infected HEp-2
cells in the absence of z-VAD-fmk (lane 3). The protein
did not accumulate in HEp-2 cells infected with d120
and maintained in the presence of z-VAD-fmk. The pro-
tein also did not accumulate in VAX-3 cells, whether
infected with HSV-1(F) or the d120 mutant.
The second series of experiments was based on stud-
ies reported earlier that the US3 protein kinase blocked
apoptosis induced by the d120 mutant at a step up-
stream of mitochondrial activation (Munger et al., 2001).
It became of interest to determine if in addition to block-
ing apoptosis, US3 also blocked the accumulation of the
M r 37,500 protein. To address this question, HEp-2 cells
were either mock infected or infected with the d120
mutant simultaneously with recombinant baculoviruses
expressing US3 (Bac-US3) or US5 (Bac-US5). The cells
were harvested 18 h after infection, solubilized, electro-
phoretically separated in denaturing polyacrylamide gel,
transferred to nitrocellulose sheet, and reacted with an
antibody to the carboxyl-terminus of ICP22. As shown in
Fig. 4, cells transduced with Bac-US3 and infected with
the d120 mutant did not accumulate the M r 37,500 pro-
tein (lane 1), whereas the cells infected with d120 alone
or in combination with Bac-US5 both accumulated the
protein (arrow, lanes 2 and 3).
The results of the two series of experiments indicate
that the accumulation of the M r 37,500 protein was
blocked by overexpression of Bcl-2 in VAX-3 cells, by
z-VAD-fmk in d120-mutant-infected HEp-2 cells, and by
transduction of the cells with US3 protein kinase. Inas-
much as overproduction of Bcl-2 blocks apoptosis in-
duced by the d120 mutant, the results indicate a con-
nection between apoptosis induced by the d120 mutant
and appearance of the M r 37,500 protein. The observa-
tion is affirmed by the finding that the US3 protein kinase
also blocks the accumulation of the protein. Last, the
observation that z-VAD-fmk also blocks the accumulation
of the protein suggests that M r 37,500 is a caspase
cleavage product. Inasmuch as both ICP22 and M r
37,500 proteins react with the W2 antibody directed
against the carboxyl-terminal region of ICP22, the results
suggest thatM r 37,500 is the carboxyl-terminal portion of
ICP22 cleaved by a caspase that had been activated by
the d120 mutant.
FIG. 3. Photograph of electrophoretically separated cell lysates re-
acted with polyclonal rabbit antibody to the carboxy-terminus of ICP22.
Replicate 25-cm2 flask cultures of HEp-2 or VAX-3 cells were mock-
infected or infected with 10 PFU of the HSV-1(F) or the d120 mutant per
cell and where indicated, incubated in the presence of z-VAD-fmk.
Eighteen hours after infection, cells were harvested, solubilized, elec-
trophoretically separated on denaturing gels, electrically transferred to
a nitrocellulose sheet, and reacted with rabbit antibody to the carboxy-
terminus of ICP22.
FIG. 4. Photograph of electrophoretically separated cell lysates re-
acted with polyclonal rabbit antibody to the carboxy-terminus of ICP22.
Replicate 25-cm2 flask cultures of HEp-2 cells were either mock-
infected or infected with d120, and where indicated coinfected with
Bac-US3 or Bac-US5. Cultures were harvested 18 h after infection,
solubilized, electrophoretically separated on denaturing gels, electri-
cally transferred to a nitrocellulose sheet, and reacted with rabbit
antibody to the carboxy-terminus of ICP22.
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Cleavage of the precursor of Mr 37,500 is a late
event blocked by transduction of US3 as late as 9 h
after infection with the d120 mutant
Earlier studies from this laboratory showed that expo-
sure of cells to Bac-US3 blocked the processing of pro-
caspase 3 when administered 6 h after d120 infection
and had a partial affect when administered as late as 9 h
after d120 infection (Munger et al., 2001). To determine
whether US3 prevented the accumulation of the M r
37,500 protein with a similar time frame, HEp-2 cells
were exposed to Bac-US3 at various times after d120
mutant infection. The cells were harvested at 18 h after
infection with the d120 mutant virus, solubilized, electro-
phoretically separated in denaturing polyacrylamide
gels, transferred to a nitrocellulose sheet, and reacted
with an antibody to the carboxyl terminus of ICP22. The
results (Fig. 5) were as follows: The M r 37,500 protein
band was detected in cells exposed to d120 only (lane
2), but not in d120-infected cells that had been exposed
to Bac-US3 at 3, 0, 3, 6, or 9 h after d120 infection
(lanes 3–7). These results indicate that Bac-US3 pre-
vented the accumulation of the M r 37,500 protein as late
as 9 h after infection. These results are consistent with
the earlier observation that US3 blocked caspase 3 acti-
vation when administered as late as 9 h after infection
with the d120 mutant (Munger et al., 2001).
ICP22 is a substrate of caspase 3
The results presented above suggested that the M r
37,500 protein is a caspase cleavage product of ICP22.
To test the hypothesis that ICP22 is a caspase 3 sub-
strate, HEp-2 cells were either mock infected or infected
with HSV-1(F) or the d120 mutant, harvested 18 h after
infection, homogenized by multiple strokes of a tight
Dounce homogenizer, clarified by centrifugation, and
treated with exogenous purified caspase 3. The results
shown in Fig. 6 were as follows: In the absence of
exogenously added caspase 3 HSV-1(F)-infected ex-
tracts exhibited abundant full-length ICP22 and no de-
tectable M r 37,500 protein (lane 4). In contrast, HSV-1(F)-
infected cell extracts that had been treated with exoge-
nous casease 3 (lane 3) exhibited very little full-length
ICP22 and accumulated a M r 37,500 protein (a) as well
as aM r 35,000 protein (b). In the absence of exogenously
added caspase 3 d120 infected cell extracts exhibited
full-length ICP22 and the M r 37,500 polypeptide (lane 2),
whereas the caspase 3 treated d120 extracts exhibited
no detectable full-length ICP22, an increase in the M r
37,500 polypeptide and the appearance of the M r 35,000
polypeptide (Lane 1). ICP22 contains four potential
caspase 3 cleavage sites, two of which, DDPD, starting
at amino acid 106, and DATD, starting at amino acid 307,
are preferred by caspase 3 based upon published
caspase 3 cleavage site specificities (Thornberry et al.,
1997). The other two sites, DRRD at amino acid 137 and
DTED at amino acid 325, are less preferred (27). While
estimation of the molecular weight of HSV-1 proteins
based on electrophoretic migration is wrought with un-
certainty because of their high proline content, cleavage
at the preferred sites, 107 and 307, could yield polypep-
FIG. 5. Photograph of electrophoretically separated cell lysates re-
acted with polyclonal rabbit antibody to the carboxy-terminus of ICP22.
Replicate 25-cm2 flask cultures of HEp-2 cells were either mock-
infected or infected with d120, and where indicated coinfected with
Bac-US3 at the times relative to d120 infection. Cultures were har-
vested 18 h after infection, solubilized, electrophoretically separated on
denaturing gels, electrically transferred to a nitrocellulose sheet, and
reacted with rabbit antibody to the carboxy-terminus of ICP22.
FIG. 6. Photograph of electrophoretically separated cell lysates re-
acted with polyclonal rabbit antibody to the carboxy-terminus of ICP22.
Replicate 25-cm2 flask cultures of HEp-2 cells were either mock-
infected or infected for 18 h at 37°C with 10 PFU of HSV-1(F) or the
d120 mutant per cell; harvested, solubilized, and where indicated,
treated with caspase 3. Extracts were electrophoretically separated on
denaturing gels, electrically transferred to a nitrocellulose sheet, and
reacted with rabbit antibody to the carboxy-terminus of ICP22.
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tides with M rs of 37,500 and 35,000, respectively. These
results suggest that ICP22 is cleaved by caspase 3,
yielding two polypeptides detectable by the antibody
made against the carboxyl-terminal domain of ICP22.
The M r 35,000 proteins are most likely either not stable
during the course of d120 infection or are cleaved only in
vitro since only the M r 37,500 protein is detected during
d120 infection.
DISCUSSION
Programmed cell death serves many functions. Fore-
most, it is a mechanism by which multicellular organisms
dispose of unwanted cells. Among the unwanted cells
are those that become infected and threaten the destruc-
tion of the organism. Viruses and HSV in particular tend
to block apoptosis since the self-destruction of the cells
decreases viral yield. The objective of the studies done
on mutants that induce apoptosis are to identify the viral
gene product(s) that induce apoptosis, the mechanisms
by which apoptosis is induced, the gene product that
blocks apoptosis, and the pathways by which apoptosis
is blocked. In the case of the d120 mutant the gene
products which induce apoptosis are not known. Al-
though only a few gene products are made after infec-
tion, we cannot exclude the possibility that tegument
proteins released from the infecting virions contribute to
the induction of apoptosis. It is possible that the US1.5
protein which is expressed with  kinetics or the US13
protein which is contained in the tegument play a role in
the induction of apoptosis by the d120 mutants as trans-
duction of US1.5 or UL13 is able to induce apoptosis and
induction of apoptosis by US1.5 and UL13 is blocked by
contransduction of US3 (Hagglund et al., 2002). Extensive
studies on the d120 mutant have shown that the mech-
anism by which apoptosis is induced is cell type depen-
dent. Apoptosis is caspase independent in d120 mutant-
infected SK-N-SH cells and caspase activation depen-
dent in HEp-2 cells (Galvan et al., 1999; Galvan et al.,
2000). Recent reports from this laboratory have shown
that US3 protein kinase blocks apoptosis induced by the
d120 mutant (Leopardi et al., 1997; Munger et al., 2001),
that it acts upstream of mitochondrial activation (Munger
et al., 2001), that in rabbit skin cells a target of the US3
protein kinase is the BAD proapoptotic member of the
Bcl-2 family (Munger and Roizman, 2001). Finally, the US3
protein kinase in the absence of other viral proteins
blocked the activation of caspases in cells transduced
with BAD (Munger and Roizman, 2001).
The objective of the studies described in this article
were to examine in detail the fate distribution and func-
tion of the  proteins—the major viral gene products
made in the d120-mutant-infected cells. Earlier studies
have shown that in cells infected with the d120 mutant
ICP0, a promiscuous transactivator product of the 0
gene, is transported to the cytoplasm where it aggre-
gates with proteosome subunits into dense cytoplasmic
structures. The focus of the studies that led to this report
was on ICP22. In the course of these studies we noted
the appearance of a protein of M r 37,500 antigenically
related to ICP22. The studies described in this article
show that the M r 37,500 protein is the product of proteo-
lytic cleavage of ICP22 caused by activation of caspases.
Specifically, we have shown that the M r 37,500 protein
does not accumulate in HEp-2 cells overexpressing Bcl-2
(VAX-3 cells), in cells transduced with the US3 protein
kinase, or in cells treated with z-VAD-fmk—a generalized
caspase inhibitor. In addition, we have shown that an
antigenically related protein identical in electrophoretic
mobility to the M r 37,500 was produced by the digestion
of wild-type virus lysates with exogeneously added
caspase 3. The product of digestion also included a
second protein antigenically related to ICP22 and with an
apparent M r of 35,000. This protein is either a product of
digestion by another enzyme activated by caspase 3 or a
protein that is rapidly degraded in d120-infected cells.
It is noteworthy that less of the M r 37,500 protein
accumulated in cells infected with the R7041 mutant than
in cells infected with the d120 mutant. The accumulation
of the ICP22 cleavage product thus appears to correlate
with the ability of the virus to induce apoptosis, inasmuch
as R7041 induces significantly less caspase 3 activity
than the d120 mutant (data not shown).
Earlier studies have indicated that multiple isoforms of
the US1.5 protein ranging in molecular weight from M r
35,000 to 48,000 also react with the W2 antibody (Ogle
and Roizman, 1999; Hagglund et al., 2002). Thus, it is
possible that the M r 37,500 protein corresponds to a
novel US1.5 isoform expressed in cells infected with the
d120 mutant but not wild-type virus. However, this expla-
nation is unlikely because the addition of exogenous
caspase 3 to lysates of cells infected with wild-type virus
produces the identicalM r 37,500 band and loss of ICP22,
indicating that the M r 37,500 protein is produced as a
result of cleavage of ICP22 by caspase 3.
Of particular interest is the observation that cells
transduced by baculoviruses encoding the US3 protein
kinase as late as 9 h after infection blocked activation of
caspases and also the accumulation of the M r 37,500
protein. These studies indicate that apoptosis induced
by the d120 mutant is induced many hours after infection
and becomes manifest by the activation of caspases.
To our knowledge ICP22 is the first HSV-1 protein
shown to be cleaved by caspases induced by proapop-
totic mutants. While we have not excluded the possibility
that other viral proteins are degraded as a consequence
of induction of programmed cell death, the significance
of the cleavage of ICP22 remains unclear. Viruses do not
evolve proteins to be cleaved by caspases to diminish
the yield of viral progeny. Furthermore, they could be
expected to evolve amino acid substitutions that pre-
clude proteolytic degradation if production of viral prog-
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eny was at stake. There are many examples of cellular
caspase substrates whose activity changes drastically
upon caspase cleavage, and one could imagine scenar-
ios in which caspase-mediated cleavage of ICP22 might
alter its activity and thus the course of infection to benefit
the virus if it were to infect an apoptotic cell. However, it
remains to be determined whether the M r 37,500 plays a
role in the biology of the infected cell.
MATERIALS AND METHODS
Cells and viruses
HEp-2 cells were obtained from the American Type
Culture Collection (Rockville, MD) and grown in Dulbec-
co’s modified Eagle’s medium (DMEM) supplemented
with 5% newborn calf serum. The creation of the VAX3
cell line was previously described (Galvan et al., 2000).
HSV-1(F) is the prototype HSV-1 strain used in the labo-
ratory (Ejercito et al., 1968). The HSV-1(KOS) d120 mu-
tant, a kind gift of N. Deluca, lacks both copies of the 4
gene and was grown in a Vero-derived cell line (E5)
expressing the 4 gene (DeLuca et al., 1985). The re-
combinant virus R7041 lacks the PstI-BamHI fragment
encoding amino acids 69 to 357 of the US3 gene (Purves
et al., 1987).
Baculoviruses
The construction of Bac-US3 and Bac-US5, recombi-
nant baculoviruses expressing US3 and glycoprotein J,
respectively, was described elsewhere (Munger et al.,
2001; Zhou et al., 2000). Briefly, the US5 or US3 ORF was
cloned into the MTS-1 transfer vector and cotransfected
with baculogold DNA (Pharmingen, San Diego, CA) to
create a recombinant baculovirus that expresses either
US3 or US5 under the control of the constitutive CMV
promoter. Efficient baculovirus gene expression in mam-
malian cells requires treatment with sodium butyrate, a
histone deacetylase inhibitor (Condreay et al., 1999). In
all experiments in which HEp-2 cells were infected with
baculoviruses, all infected or treated cultures were ex-
posed to medium containing 10 mM sodium butyrate
after 2 h of incubation at 37°C with approximately 15 PFU
of the indicated recombinant baculoviruses per cell.
Immunoblots
Cells were scraped into their medium, pelleted by low
speed centrifugation, rinsed twice with PBS A (0.14 M
NaCl, 3 mM KCl, 10 mM Na2HPO4, 1.5 mM KH2PO4), lysed
in RIPA buffer [1% NP-40, 0.5% sodium deoxycholate, and
0.1% SDS in PBS A containing a protease inhibitor cock-
tail (Roche Pharmaceuticals, Nutley, NJ)], and stored on
wet ice for 10 min before centrifugation at 14,000 g for 10
min. The protein concentration of the supernatant fluids
was determined with the aid of the Bio-Rad protein assay
(Bio-Rad Laboratories, Hercules, CA) according to direc-
tions provided by the manufacturer. Samples containing
75 g of protein each were denatured in disruption buffer
(50 mM Tris pH 7.0, 2.75% sucrose, 5% -mercaptoetha-
nol, 2% sodium dodecylsulfate), boiled for 5 min, electro-
phoretically separated in a 12% denaturing polyacryl-
amide gel, electrically transferred to a nitrocellulose
sheet, blocked, and reacted with a 1:3000 dilution of W2,
a rabbit polyclonal antibody specific for the carboxyl
terminus of ICP22/US1.5 described elsewhere (Leopardi
et al., 1997b).
Caspase 3 cleavage assay
HEp-2 cells grown in roller bottle cultures were either
mock infected or infected with 10 PFU of HSV-1(F) or the
d120 mutant virus per cell. Where indicated, the cells
were infected with 10 PFU of HSV-1(F) or the d120
mutant per cell. After 18 h of infection, the cells were
collected and resuspended in ice-cold buffer A [20 mM
HEPES, 10 mM KCl, 1.5 mM MgCl2, 1 mM EDTA, 1 mM
EGTA, 1 mM DTT, 250 mM sucrose, and 0.1 mM phenyl-
methylsulfonyl fluoride (PMSF) to a volume of approxi-
mately 10 the cell pellet]. After 15 min on ice, the cells
were homogenized in a Dounce homogenizer and then
centrifuged for 10 min at 750 g to remove unlysed cells
and nuclei. The supernatant fluids were transferred to
new tubes and centrifuged again at 10,000 g for 20 min.
The extract (80 l) was then treated with 20 ng caspase
3 (Biomol, Plymouth Meeting, PA) where indicated and
subsequently incubated at 37°C for 90 min before stop-
ping the reaction with disruption buffer.
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